Sterling TR - Search Results

1

Effect of Dysglycemia on Urinary Lipid Mediator Profiles in Persons With Pulmonary Tuberculosis.

Arriaga MB, Karim F, Queiroz ATL, Araújo-Pereira M, Barreto-Duarte B, Sales C, Moosa MS, Mazibuko M, Milne GL, Maruri F, Serezani CH, Koethe JR, Figueiredo MC, Kritski AL, Cordeiro-Santos M, Rolla VC, Sterling TR, Leslie A, Andrade BB. Arriaga MB, et al. Among authors: sterling tr. Front Immunol. 2022 Jul 8;13:919802. doi: 10.3389/fimmu.2022.919802. eCollection 2022. Front Immunol. 2022. PMID: 35874781 Free PMC article.

2

Immune function in young children with previous pulmonary or miliary/meningeal tuberculosis and impact of BCG vaccination.

Sterling TR, Martire T, de Almeida AS, Ding L, Greenberg DE, Moreira LA, Elloumi H, Torres AP, Sant'Anna CC, Calazans E, Paraguassu G, Gebretsadik T, Shintani A, Miller K, Kritski A, Lapa e Silva JR, Holland SM. Sterling TR, et al. Pediatrics. 2007 Oct;120(4):e912-21. doi: 10.1542/peds.2006-3150. Pediatrics. 2007. PMID: 17908747

3

Fluoroquinolone resistance in Mycobacterium tuberculosis: the effect of duration and timing of fluoroquinolone exposure.

Devasia RA, Blackman A, Gebretsadik T, Griffin M, Shintani A, May C, Smith T, Hooper N, Maruri F, Warkentin J, Mitchel E, Sterling TR. Devasia RA, et al. Among authors: sterling tr. Am J Respir Crit Care Med. 2009 Aug 15;180(4):365-70. doi: 10.1164/rccm.200901-0146OC. Epub 2009 May 29. Am J Respir Crit Care Med. 2009. PMID: 19483111 Free PMC article.

4

Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting.

Wester CW, Koethe JR, Shepherd BE, Stinnette SE, Rebeiro PF, Kipp AM, Hong H, Bussmann H, Gaolathe T, McGowan CC, Sterling TR, Marlink RG. Wester CW, et al. Among authors: sterling tr. AIDS. 2011 Jul 31;25(12):1471-9. doi: 10.1097/QAD.0b013e328347f9d4. AIDS. 2011. PMID: 21572309 Free PMC article.

5

Chronic lung disease and HIV infection are risk factors for recurrent tuberculosis in a low-incidence setting.

Pettit AC, Kaltenbach LA, Maruri F, Cummins J, Smith TR, Warkentin JV, Griffin MR, Sterling TR. Pettit AC, et al. Among authors: sterling tr. Int J Tuberc Lung Dis. 2011 Jul;15(7):906-11. doi: 10.5588/ijtld.10.0448. Int J Tuberc Lung Dis. 2011. PMID: 21682963 Free PMC article.

6

An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy.

Koethe JR, Jenkins CA, Shepherd BE, Stinnette SE, Sterling TR. Koethe JR, et al. Among authors: sterling tr. Clin Infect Dis. 2011 Nov;53(9):952-60. doi: 10.1093/cid/cir606. Epub 2011 Sep 26. Clin Infect Dis. 2011. PMID: 21946189 Free PMC article.

7

Increased frequency of regulatory T cells and T lymphocyte activation in persons with previously treated extrapulmonary tuberculosis.

de Almeida AS, Fiske CT, Sterling TR, Kalams SA. de Almeida AS, et al. Among authors: sterling tr. Clin Vaccine Immunol. 2012 Jan;19(1):45-52. doi: 10.1128/CVI.05263-11. Epub 2011 Oct 28. Clin Vaccine Immunol. 2012. PMID: 22038848 Free PMC article.

8

A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system.

Maruri F, Sterling TR, Kaiga AW, Blackman A, van der Heijden YF, Mayer C, Cambau E, Aubry A. Maruri F, et al. Among authors: sterling tr. J Antimicrob Chemother. 2012 Apr;67(4):819-31. doi: 10.1093/jac/dkr566. Epub 2012 Jan 25. J Antimicrob Chemother. 2012. PMID: 22279180 Free PMC article. Review.

9

Microcolonies in fluoroquinolone agar proportion susceptibility testing of Mycobacterium tuberculosis: an indicator of drug resistance.

Blackman A, May S, Devasia RA, Maruri F, Stratton C, Sterling TR. Blackman A, et al. Among authors: sterling tr. Eur J Clin Microbiol Infect Dis. 2012 Sep;31(9):2177-82. doi: 10.1007/s10096-012-1552-7. Epub 2012 Feb 10. Eur J Clin Microbiol Infect Dis. 2012. PMID: 22322359 Free PMC article.

10

Abnormal immune responses in persons with previous extrapulmonary tuberculosis in an in vitro model that simulates in vivo infection with Mycobacterium tuberculosis.

Fiske CT, de Almeida AS, Shintani AK, Kalams SA, Sterling TR. Fiske CT, et al. Among authors: sterling tr. Clin Vaccine Immunol. 2012 Aug;19(8):1142-9. doi: 10.1128/CVI.00221-12. Epub 2012 Jun 6. Clin Vaccine Immunol. 2012. PMID: 22675156 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

360 results

Search Page